Dairy Focus, 181 Wharparilla Drive, Echuca, Victoria, 3564, Australia.
Zoetis Australia, 5 Rider Blvd, Rhodes, New South Wales, 2138, Australia.
J Dairy Sci. 2022 Feb;105(2):1504-1518. doi: 10.3168/jds.2021-20955. Epub 2021 Dec 23.
The objectives for this study were to (1) describe the pathogen profile in quarters from cows with clinical mastitis and in cows with subclinical mastitis in southeastern Australia; and (2) describe antimicrobial susceptibility among isolated pathogens. As a secondary objective, we aimed to compare antimicrobial resistance prevalence in pathogens isolated from clinical and subclinical mastitis samples. A convenience sample of dairy herds (n = 65) from 4 regions in southeastern Australia (Gippsland, Northern Victoria, Tasmania, Western Victoria) were invited to submit milk samples from cows with clinical and subclinical mastitis over a 14-mo period (January 2011 to March 2012). Farmers were instructed to collect aseptic quarter milk samples from the first 10 cases of clinical mastitis for each month of the study. In addition, farmers submitted composite milk samples from cows with subclinical mastitis at 1 or 2 sampling occasions during the study period. Aerobic culture and biochemical tests were used to identify isolates. Isolates were classified as susceptible, intermediate, or resistant to a panel of antimicrobial agents based on the zone of growth inhibition around antimicrobial-impregnated disks, with antimicrobial resistance (AMR) classified as nonsusceptibility by combining intermediate and resistant groups into a single category. Generalized linear mixed models were used to compare the prevalence of AMR between clinical and subclinical mastitis isolates. For clinical mastitis samples (n = 3,044), 472 samples (15.5%) were excluded for contamination. Of the remaining samples (n = 2,572), the most common results were Streptococcus uberis (39.2%), no growth (27.5%), Staphylococcus aureus (10.6%), Escherichia coli (8.4%), and Streptococcus dysgalactiae (6.4%). For subclinical mastitis samples (n = 1,072), 425 (39.6%) were excluded due to contamination. Of the remaining samples (n = 647), the most common results were no growth (29.1%), Staph. aureus (29.1%), and Strep. uberis (21.6%). The prevalence of AMR among common isolates was low for the majority of antimicrobial agents. Exploratory analysis found that the probability of Staph. aureus demonstrating resistance to penicillin was 5.16 times higher (95% confidence interval: 1.68, 15.88) in subclinical isolates relative to clinical Staph. aureus isolates. A similar association was observed for amoxicillin with subclinical Staph. aureus isolates being 4.70 times (95% confidence interval: 1.49, 14.75) more likely to be resistant than clinical Staph. aureus isolates. We concluded that the most common bacteria causing clinical mastitis in dairy herds in Australia is likely to be Strep. uberis, whereas Staph. aureus is likely to be the most common cause of subclinical mastitis. Despite decades of antimicrobial use to control these organisms, AMR appears to be uncommon.
(1) 描述澳大利亚东南部临床型和亚临床型乳腺炎奶牛乳房内病原体的分布特征;(2) 描述分离病原体的抗菌药物敏感性。作为次要目标,我们旨在比较临床型和亚临床型乳腺炎样本中分离病原体的抗菌药物耐药率。本研究采用便利抽样方法,选择澳大利亚东南部(吉普斯兰、北维多利亚、塔斯马尼亚、西维多利亚)4 个地区的 65 个奶牛场(n = 65),在 14 个月(2011 年 1 月至 2012 年 3 月)内收集临床型和亚临床型乳腺炎奶牛的乳样。研究期间,要求农民每月从第 1 次临床型乳腺炎的前 10 个乳区采集无菌乳房奶样。此外,农民在研究期间的 1 或 2 次采样时提交亚临床型乳腺炎奶牛的混合乳样。采用需氧培养和生化试验来鉴定分离株。根据抗菌药物浸渍纸片周围的抑菌圈大小,将分离株分为敏感、中介和耐药,将中介和耐药合并为一个耐药组,从而将抗菌药物耐药(antimicrobial resistance,AMR)定义为不敏感。采用广义线性混合模型比较临床型和亚临床型乳腺炎分离株的 AMR 流行率。对于临床型乳腺炎样本(n = 3044),有 472 个(15.5%)样本因污染而被排除。在剩余的 2572 个样本中,最常见的结果是无乳链球菌(Streptococcus uberis,39.2%)、无生长(27.5%)、金黄色葡萄球菌(Staphylococcus aureus,10.6%)、大肠杆菌(Escherichia coli,8.4%)和停乳链球菌(Streptococcus dysgalactiae,6.4%)。对于亚临床型乳腺炎样本(n = 1072),有 425 个(39.6%)样本因污染而被排除。在剩余的 647 个样本中,最常见的结果是无生长(29.1%)、金黄色葡萄球菌(29.1%)和无乳链球菌(21.6%)。大多数抗菌药物的常见分离株的 AMR 流行率较低。探索性分析发现,与临床金黄色葡萄球菌分离株相比,亚临床金黄色葡萄球菌分离株对青霉素的耐药率高 5.16 倍(95%置信区间:1.68,15.88)。对阿莫西林也观察到类似的关联,亚临床金黄色葡萄球菌分离株对阿莫西林的耐药率比临床金黄色葡萄球菌分离株高 4.70 倍(95%置信区间:1.49,14.75)。本研究得出结论,澳大利亚奶牛场引起临床型乳腺炎的最常见细菌可能是无乳链球菌,而金黄色葡萄球菌可能是亚临床型乳腺炎的最常见病因。尽管几十年来一直使用抗菌药物来控制这些病原体,但 AMR 似乎并不常见。